LD

Leslie Donato

Executive Vice President & Chief Strategy Officer at Cencora

Greater Philadelphia

Invests in

Stages:

  • Min Investment:

    $1,000,000.00
  • Max Investment:

    $10,000,000.00
  • Target Investment:

    $5,500,000.00

Education

Work Experience

2019

  • Executive Vice President & Chief Strategy Officer

    2019

    Partnering with CEO and executive leadership team to further develop the strategy, identify and prioritize strategic investment opportunities, and define the innovation agenda. Leading both the strategy and business development functions.

2009 - 2019

  • Vice President Strategy, Pharmaceuticals

    2015 - 2019

    Lead the development of an integrated (research, development, commercial) global pharmaceutical strategy in 2014 and a US growth strategy. Responsible for supporting the CEO of the Pharmaceutical Division in defining the long-range strategy and executing key strategic projects. Lead strategy development across business segments and functions. Supported portfolio investment decisions through leadership of the holistic portfolio review process and as a member of the Global Product Development Committee.

  • VP and General Manager, Hematology and Neurology, United States

    2011 - 2015

    Lead the Specialty Therapeutics Business Unit, comprising of Hematology and Neurology Portfolio.

  • VP Neurology, Head Global Brand Team Betaferon

    2010 - 2011

    Lead Neurology Therapeutic Area with global revenues over €1.2 billion driven by Bayer’s largest pharmaceutical brand, Betaferon. Responsible for developing and driving global brand and therapeutic area strategy. Lead cross-functional global brand team (Betaferon).

  • Global Head of Regional Business Units, Specialty Medicine Business Unit

    2009 - 2011

    Responsible for leading the regional business units of the Specialty Medicine Business Unit. The Business Unit comprises several therapeutic areas including Oncology, Hematology, Neurology and Ophthalmology. The Regional Business Units (RBUs) customize global brand strategy to reflect regional market dynamics and partner with country leadership to execute these strategies.

1995 - 2009

  • Principal

    1995 - 2009

    Lead engagements across multiple clients to guide top management in generating positive and lasting impact. A leader in McKinsey's Pharmaceutical & Medical Products Practice specializing in Strategy, Marketing, Sales, Business Development and Organizational Effectiveness. Beyond traditional pharmaceuticals, also led work in consumer health and the generics industry. A founding Partner of the Philadelphia Office and leader of the Mid-Atlantic Offices Womens' Initiative

1991 - 1993

  • Business Analyst

    1991 - 1993

    Developed diversified skill set and broad management perspective through projects spanning a spectrum of management functions and industries including manufacturing, financial services, public sector, and health-care. Major functions included: business process reengineering, new product development, and strategy.